131 related articles for article (PubMed ID: 3596609)
1. Carbamazepine and carbamazepine-10,11-epoxide pharmacokinetics in an overdose patient.
Patsalos PN; Krishna S; Elyas AA; Lascelles PT
Hum Toxicol; 1987 May; 6(3):241-4. PubMed ID: 3596609
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose.
Vree TB; Janssen TJ; Hekster YA; Termond EF; van de Dries AC; Wijnands WJ
Ther Drug Monit; 1986; 8(3):297-304. PubMed ID: 3750374
[TBL] [Abstract][Full Text] [Related]
3. Carbamazepine and carbamazepine-10,11-epoxide clearance measurements during continuous venovenous hemofiltration in a massive overdose.
Smollin CG; Petrie MS; Kearney T
Clin Toxicol (Phila); 2016 Jun; 54(5):424-7. PubMed ID: 26942940
[TBL] [Abstract][Full Text] [Related]
4. Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy.
Contin M; Riva R; Albani F; Perucca E; Lamontanara G; Baruzzi A
Eur J Clin Pharmacol; 1985; 29(2):211-4. PubMed ID: 4076320
[TBL] [Abstract][Full Text] [Related]
5. In vivo binding characteristics of carbamazepine and carbamazepine-10,11-epoxide to serum proteins in paediatric patients with epilepsy.
Kodama Y; Tsutsumi K; Kuranari M; Kodama H; Fujii I; Takeyama M
Eur J Clin Pharmacol; 1993; 44(3):291-3. PubMed ID: 8491247
[TBL] [Abstract][Full Text] [Related]
6. Effect of lamotrigine on carbamazepine epoxide/carbamazepine serum concentration ratios in adult patients with epilepsy.
Gidal BE; Rutecki P; Shaw R; Maly MM; Collins DM; Pitterle ME
Epilepsy Res; 1997 Oct; 28(3):207-11. PubMed ID: 9332885
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing simultaneous concentrations of total and free carbamazepine and carbamazepine-10, 11-epoxide in serum of children with epilepsy.
Elyas AA; Patsalos PN; Agbato OA; Brett EM; Lascelles PT
Ther Drug Monit; 1986; 8(3):288-92. PubMed ID: 3750372
[TBL] [Abstract][Full Text] [Related]
8. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L
Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
[TBL] [Abstract][Full Text] [Related]
10. Effect of denzimol on carbamazepine and carbamazepine-10,11-epoxide concentrations in serum, liver, spleen and different brain regions of the rat: an inhibitory metabolic interaction.
Patsalos PN; Alavijeh MS; Brownhill W; Lascelles PT
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):111-4. PubMed ID: 3368010
[TBL] [Abstract][Full Text] [Related]
11. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
12. No increase in carbamazepine-10,11-epoxide during addition of lamotrigine treatment in children.
Eriksson AS; Boreus LO
Ther Drug Monit; 1997 Oct; 19(5):499-501. PubMed ID: 9357090
[TBL] [Abstract][Full Text] [Related]
13. Free and total serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in infancy and childhood.
Riva R; Contin M; Albani F; Perucca E; Lamontanara G; Baruzzi A
Epilepsia; 1985; 26(4):320-2. PubMed ID: 4006891
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous plasma carbamazepine and carbamazepine-epoxide concentrations in pharmacokinetic and bioavailability studies.
Hooper WD; King AR; Patterson M; Dickinson RG; Eadie MJ
Ther Drug Monit; 1985; 7(1):36-40. PubMed ID: 3992620
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of carbamazepine and its 10,11-epoxide metabolite in children.
Rane A; Höjer B; Wilson JT
Clin Pharmacol Ther; 1976 Mar; 19(3):276-83. PubMed ID: 1261166
[TBL] [Abstract][Full Text] [Related]
16. Carbamazepine-10,11-epoxide in therapeutic drug monitoring.
Potter JM; Donnelly A
Ther Drug Monit; 1998 Dec; 20(6):652-7. PubMed ID: 9853982
[TBL] [Abstract][Full Text] [Related]
17. Interaction of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine, with valproate: a pharmacokinetic study.
Pisani F; Caputo M; Fazio A; Oteri G; Russo M; Spina E; Perucca E; Bertilsson L
Epilepsia; 1990; 31(3):339-42. PubMed ID: 2111769
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
Eichelbaum M; Tomson T; Tybring G; Bertilsson L
Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication.
Rambeck B; May T; Juergens U
Ther Drug Monit; 1987 Sep; 9(3):298-303. PubMed ID: 3672573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
